640 related articles for article (PubMed ID: 11580213)
1. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
2. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
[TBL] [Abstract][Full Text] [Related]
3. Detection of residual pertussis toxin in vaccines using a modified ribosylation assay.
Yuen CT; Canthaboo C; Menzies JA; Cyr T; Whitehouse LW; Jones C; Corbel MJ; Xing D
Vaccine; 2002 Nov; 21(1-2):44-52. PubMed ID: 12443661
[TBL] [Abstract][Full Text] [Related]
4. Transition-state structure for the ADP-ribosylation of recombinant Gialpha1 subunits by pertussis toxin.
Scheuring J; Berti PJ; Schramm VL
Biochemistry; 1998 Mar; 37(9):2748-58. PubMed ID: 9485425
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin catalyzed ADP-ribosylation of a 41 kDa G-protein impairs insulin-stimulated glucose metabolism in BC3H-1 myocytes.
Moises RS; Heidenreich KA
J Cell Physiol; 1990 Sep; 144(3):538-45. PubMed ID: 2118147
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation of alpha i3C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin.
Finck-Barbançon V; Barbieri JT
Biochemistry; 1995 Jan; 34(3):1070-5. PubMed ID: 7827022
[TBL] [Abstract][Full Text] [Related]
7. Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of the trimeric GTP-binding proteins.
Graf R; Codina J; Birnbaumer L
Mol Pharmacol; 1992 Nov; 42(5):760-4. PubMed ID: 1435750
[TBL] [Abstract][Full Text] [Related]
8. ADP-ribosylation of G alpha i and G alpha o in pituitary cells enhances their recognition by antibodies directed against their carboxyl termini.
Cussac D; Kordon C; Enjalbert A; Saltarelli D
J Recept Signal Transduct Res; 1996; 16(3-4):169-90. PubMed ID: 8897310
[TBL] [Abstract][Full Text] [Related]
9. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
[TBL] [Abstract][Full Text] [Related]
10. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
[TBL] [Abstract][Full Text] [Related]
11. Failure of [32P]ADP-ribosylation by pertussis toxin to determine Gi alpha content in membranes from various human tissues. Improved radioimmunological quantification using the 125I-labelled C-terminal decapeptide of retinal transducin.
Böhm M; Larisch K; Erdmann E; Camps M; Jakobs K; Gierschik P
Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):223-9. PubMed ID: 1906710
[TBL] [Abstract][Full Text] [Related]
12. Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.
West RE; Moss J; Vaughan M; Liu T; Liu TY
J Biol Chem; 1985 Nov; 260(27):14428-30. PubMed ID: 3863818
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent labeling of signal-transducing G-proteins. Pertussis toxin-catalyzed etheno-ADP ribosylation of transducin.
Hingorani VN; Ho YK
J Biol Chem; 1988 Dec; 263(36):19804-8. PubMed ID: 3143731
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of the in vitro activation of pertussis toxin by ATP.
Krueger KM; Barbieri JT
J Biol Chem; 1993 Jun; 268(17):12570-8. PubMed ID: 8509398
[TBL] [Abstract][Full Text] [Related]
15. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.
Locht C; Antoine R
Biochimie; 1995; 77(5):333-40. PubMed ID: 8527486
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins.
Kenimer JG; Probst PG; Karpas AB; Burns DL; Kaslow HR
Dev Biol Stand; 1991; 73():133-41. PubMed ID: 1778307
[TBL] [Abstract][Full Text] [Related]
17. Evidence that myocardial pertussis toxin substrates are uniquely altered in acute murine Chagas' disease in a manner unrelated to myocardial dysfunction.
Huang H; Tanowitz HB; Oz HS; Wittner M; Spray DC; Bilezikian JP; Morris SA
J Mol Cell Cardiol; 1993 Nov; 25(11):1293-304. PubMed ID: 8301665
[TBL] [Abstract][Full Text] [Related]
18. ADP-ribosylation of alpha-Gi proteins by pertussis toxin. Positional dissection of acceptor sites using membrane anchored synthetic peptides.
von Olleschik-Elbheim L; el Bayâ A; Schmidt MA
Methods Mol Biol; 2000; 145():203-17. PubMed ID: 10820724
[No Abstract] [Full Text] [Related]
19. Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
Avigan J; Murtagh JJ; Stevens LA; Angus CW; Moss J; Vaughan M
Biochemistry; 1992 Aug; 31(33):7736-40. PubMed ID: 1510959
[TBL] [Abstract][Full Text] [Related]
20. C-terminal modifications of pertussis toxin-sensitive G-protein alpha-subunits differentially affect immunoreactivity. Evidence against endogenous ADP-ribosylation in human heart, lung, thrombocytes and adipose tissue.
Böhm M; Gräbel C; Kirchmayr R; Lensche H; Erdmann E; Gierschik P
Biochem Pharmacol; 1993 Dec; 46(12):2145-54. PubMed ID: 8274148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
